DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Purinethol (Mercaptopurine) - Current Clinical Trials

 
 



Purinethol Related Clinical Trials

Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease Patients [Completed]

Multicenter Clinical Efficacy and Safety Study of Delayed Release 6MP in Crohn's Disease [Terminated]

Study on Two Different Formulations of 6-mercaptopurine. Tablet Versus Oral Liquid [Recruiting]

Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and Tablets [Recruiting]

Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions [Completed]

NOPHO ALL-2008 Pilot Study on Consolidation Therapy for Children and Adolescents With Acute Lymphoblastic Leukemia [Completed]

Fasting Study of Mercaptopurine 50 mg and PurinetholŪ Tablets 50 mg [Completed]

Open Label Extension Study to Protocol C2/13/DR-6MP-02 [Withdrawn]

ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation Therapy [Recruiting]

Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission [Recruiting]

A Clinical Trial in Patients With BRCA Defective Tumours [Completed]

Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Not yet recruiting]

Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma [Not yet recruiting]

A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL [Recruiting]

Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia [Completed]

Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia [Completed]

Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease [Completed]

Ruxolitinib or Dasatinib With Chemotherapy in Patients With Philadelphia Chromosome (Ph)-Like Acute Lymphoblastic Leukemia (ALL) [Recruiting]

Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission [Active, not recruiting]

Bioequivalence Study of 6-Mercaptopurine Under Fasting Conditions [Completed]

Adalimumab for the Management of Post-operative Crohn's Disease (CD) [Not yet recruiting]

Cost-effectiveness of TPMT Pharmacogenetics [Completed]

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia [Completed]

Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia [Completed]

Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma [Active, not recruiting]

Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma [Completed]

Thiopurine Induced Pancreatitis in IBD Patients [Recruiting]

LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis [Recruiting]

Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia [Completed]

Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma [Recruiting]

Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults [Recruiting]

NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma [Recruiting]

Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) [Active, not recruiting]

Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies [Recruiting]

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma [Not yet recruiting]

Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Completed]

Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia [Terminated]

The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease [Recruiting]

Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms [Completed]

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia [Active, not recruiting]

Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia [Recruiting]

Clofarabine or High-Dose Cytarabine and Pegaspargase in Children With ALL [Recruiting]

Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma [Recruiting]

Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia [Active, not recruiting]

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia [Active, not recruiting]

Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia [Active, not recruiting]

Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia [Completed]

Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome [Withdrawn]

Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia [Completed]

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia [Completed]

Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma [Completed]

A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia [Recruiting]

The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia [Recruiting]

Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma [Completed]

Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator [Not yet recruiting]

Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure [Recruiting]

Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma [Completed]

A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia [Recruiting]

Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients [Active, not recruiting]

CINJALL: Treatment for Children With Acute Lymphocytic Leukemia [Completed]

Two Combination Chemotherapy Regimens in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia [Active, not recruiting]

Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission [Completed]

Treatment of Older Adults With Acute Lymphoblastic Leukemia [Active, not recruiting]

Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia [Completed]

Treatment of High Risk Adult Acute Lymphoblastic Leukemia [Recruiting]

Phase III Trial in Acute Promyelocytic Leukemia Patients [Active, not recruiting]

S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Completed]

Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome [Not yet recruiting]

A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy [Not yet recruiting]

On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection [Completed]

Pentoxifylline In Pediatric Acute Lymphoblastic Leukemia During Induction [Recruiting]

Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia [Completed]

MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate [Recruiting]

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93) [Completed]

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99) [Completed]

A Study in Adults With Untreated Acute Lymphoblastic Leukemia [Active, not recruiting]

Intensified Post Remission Therapy Containing PEG-Asparaginase [Completed]

ALL Adult Consortium Trial: Adult ALL Trial [Active, not recruiting]

Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia [Not yet recruiting]

Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017